We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It also focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, alzheimers, bone, joint center specialties, and others. The company was incorporated in 1973 and is based in Secunderabad, India.
TODAY'S HIGH
1515
TODAY'S LOW
1492.05
52 WEEK HIGH
1668.4
52 WEEK LOW
1113.25
% of Shares Held by
All Insider
42.07%
% of Shares Held by
Institutions
45.07%
% of Float Held by
Institutions
77.80%
Number of Institutions
Holding Shares
37
MARKET CAP
12042.59 Cr.
ETERPRISE VALUE
12511.18 Cr.
NO. OF SHARES
8 Cr.
BOOK VALUE
195.79
DIV. YIELD
None%
DEBT
476.55 Cr.
GROSS PROFIT
983.24 Cr.
CASH
247.61 Cr.
REVENUE
1825.49 Cr.
REVENUE/SHARE
222.344
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | -229.57 Cr. | -2.39 Cr. | -7.55 Cr. |
| Change To Liabilities | 0 | 23.92 Cr. | 13.43 Cr. | 2.48 Cr. |
| Total cashflows from Investing Activities | 0 | -354.17 Cr. | -124.71 Cr. | -109.76 Cr. |
| Net Borrowings | 0 | -58.04 Cr. | -11.32 Cr. | -89.25 Cr. |
| Total Cash from Financing Activities | 0 | 9.82 Cr. | -44.33 Cr. | -27.03 Cr. |
| Other Liabilities | 0 | -33.84 Cr. | 2.99 Cr. | 6.77 Cr. |
| Total Assets | 0 | 95.02 Cr. | 95.02 Cr. | 88 Cr. |
| Net Income | 343.79 Cr. | 201.21 Cr. | 119.18 Cr. | -47.65 Cr. |
| Change in Cash | 0 | 11.61 Cr. | 32.45 Cr. | -2.89 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 0 | 355.97 Cr. | 201.50 Cr. | 133.90 Cr. |
| Depreciation | 0 | 68.22 Cr. | 69.33 Cr. | 55.37 Cr. |
| Other Cashflows from Investing Activities | 0 | 4.25 Cr. | 1.89 Cr. | 1.32 Cr. |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | 0 | 6.29 Cr. | -3.04 Cr. | -5.73 Cr. |
| Change to Account Receivables | 0 | 17.74 Cr. | -13.20 Cr. | -26.86 Cr. |
| Other Cashflows from Financing Activities | 0 | -27.15 Cr. | -33.01 Cr. | -25.78 Cr. |
| Change to Net Income | 0 | 71.10 Cr. | 11.53 Cr. | 148.77 Cr. |
| Capital Expenditures | 0 | -94.42 Cr. | -51.98 Cr. | -77.34 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 456.85 Cr. | 279.01 Cr. | 140.52 Cr. | -15.04 Cr. |
| Minority Interest | 0 | 12.46 Cr. | 13.30 Cr. | 25.31 Cr. |
| Net Income | 463.38 Cr. | 303.13 Cr. | 176.44 Cr. | 28.12 Cr. |
| Selling General Administrative | 0 | 17.82 Cr. | 16.24 Cr. | 17.20 Cr. |
| Gross Profit | 1054.02 Cr. | 776.43 Cr. | 636.14 Cr. | 518.51 Cr. |
| Ebit | 463.38 Cr. | 303.13 Cr. | 176.44 Cr. | 28.12 Cr. |
| Operating Income | 463.38 Cr. | 303.13 Cr. | 176.44 Cr. | 28.12 Cr. |
| Other Operating Expenses | 517.97 Cr. | 385.11 Cr. | 372.27 Cr. | 412.28 Cr. |
| Interest Expense | -16.03 Cr. | -29.30 Cr. | -39.12 Cr. | -44.70 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 113.06 Cr. | 73.53 Cr. | 25.45 Cr. | 33.54 Cr. |
| Total Revenue | 1671.09 Cr. | 1329.93 Cr. | 1122.67 Cr. | 920.35 Cr. |
| Total Operating Expenses | 1207.71 Cr. | 1026.80 Cr. | 946.22 Cr. | 892.22 Cr. |
| Cost of Revenue | 617.07 Cr. | 553.50 Cr. | 486.52 Cr. | 401.83 Cr. |
| Total Other Income Expense Net | -6.53 Cr. | -24.12 Cr. | -35.92 Cr. | -43.16 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 343.79 Cr. | 205.47 Cr. | 115.07 Cr. | -48.58 Cr. |
| Net Income Applicable to Common Shares | 343.79 Cr. | 201.21 Cr. | 119.18 Cr. | -47.65 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 0 | 24.74 Cr. | 26.23 Cr. | 26.41 Cr. |
| Capital Surplus | 0 | 844.81 Cr. | 752.58 Cr. | 752.58 Cr. |
| Total Liabilities | 0 | 559.95 Cr. | 584.46 Cr. | 551.70 Cr. |
| Stock Holder Equity | 0 | 863.73 Cr. | 598.12 Cr. | 540.58 Cr. |
| Minority Interest | 0 | 12.46 Cr. | 13.30 Cr. | 25.31 Cr. |
| Other Liabilities | 0 | 29.08 Cr. | 15.15 Cr. | 20.58 Cr. |
| Total Assets | 0 | 1436.15 Cr. | 1195.89 Cr. | 1117.60 Cr. |
| Common Stock | 0 | 77.59 Cr. | 74.49 Cr. | 74.49 Cr. |
| Retained Earnings | 0 | -64.43 Cr. | -235.01 Cr. | -292.55 Cr. |
| Other Liabilities | 0 | 53.69 Cr. | 51.37 Cr. | 62.58 Cr. |
| Good Will | 0 | 84.77 Cr. | 84.77 Cr. | 76.23 Cr. |
| Treasury Stock | 0 | 5.76 Cr. | 6.07 Cr. | 6.07 Cr. |
| Other Assets | 0 | 42.47 Cr. | 57.85 Cr. | 80.43 Cr. |
| Cash | 0 | 52.12 Cr. | 40.51 Cr. | 8.06 Cr. |
| Current Liabilities | 0 | 278.32 Cr. | 218.81 Cr. | 200.87 Cr. |
| Long Term Asset Charges | 0 | 2.93 Cr. | 1.41 Cr. | 3.79 Cr. |
| Short Long Term Debt | 0 | 30.59 Cr. | 41.95 Cr. | 27.81 Cr. |
| Other Stockholder Equity | 0 | 5.76 Cr. | 6.07 Cr. | 6.07 Cr. |
| Property Plant Equipment | 0 | 830.80 Cr. | 807.19 Cr. | 760.68 Cr. |
| Total Cur. Assets | 0 | 451.19 Cr. | 219.82 Cr. | 173.85 Cr. |
| Long Term Investments | 0 | 2.15 Cr. | 0 | 0 |
| Net Tangible Assets | 0 | 754.21 Cr. | 487.11 Cr. | 437.94 Cr. |
| Short Term Investments | 0 | 232.11 Cr. | 2.10 Cr. | 2.13 Cr. |
| Net Receivables | 0 | 127.76 Cr. | 138.79 Cr. | 132.30 Cr. |
| Long Term Debt | 0 | 184.60 Cr. | 268.71 Cr. | 242.72 Cr. |
| Inventory | 0 | 24.08 Cr. | 30.37 Cr. | 26.86 Cr. |
| Accounts Payable | 0 | 131.87 Cr. | 123.43 Cr. | 104.06 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account